Citations 1
A phase I/II trial adding poly(ADP-ribose) polymerase (PARP) inhibitor veliparib to induction carboplatin-paclitaxel (Carbo-Tax) in patients with head and neck squamous cell carcinoma (HNSCC) Alliance A091101.
Foster, Nathan R. , Zoroufy, Alexander J., Souza, Jonas A. de, Jelinek, Michael J. , Schwartz, Gary K. , Münster, Pamela N. , Seiwert, Tanguy Y. , Vokes, Everett E.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 6031-6031
